510(k) Report

510(k) · Cleared

Cleared

Emit 2000 Cyclosporine Specific Assay

K053061510(k) TraditionalCleared Feb 6, 200698-day reviewClass II21 CFR 862.1235

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Dade Behring, Inc. · MKW Cyclosporine

Cleared on Feb 6, 2006 as substantially equivalent to P890025 (Abbott Laboratories, 1989) after a 98-day review. Its family tree reaches back 1 generation to 1989.

Decided
Feb 6, 2006
Review
98 days
Class
Class II
Product code
MKW
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to P890025 (1989). No later device cites it as a predicate yet.

P890025 · TD Cyclosporine and Metabolites Serum Assay · Abbott Laboratories · 1989 · recalled19851990199520002005
  1. Root · 1 generation backP890025 TD Cyclosporine and Metabolites Serum AssayAbbott Laboratories · 1989 · Recalled
  2. This deviceK053061 Emit 2000 Cyclosporine Specific AssayDade Behring, Inc. · 2006
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1P890025TD Cyclosporine and Metabolites Serum AssayAbbott Laboratories19891
0 (this device)K053061Emit 2000 Cyclosporine Specific AssayDade Behring, Inc.2006—
FIG. 1 — Lineage of K053061, 1989–2006Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MKW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*P890025TD Cyclosporine and Metabolites Serum Assay
Summary page 1
…Emit® 2000 Cyclosporine Specific Assay / Class 11 3. Identification of the Predicate Device Abbott TDx®/TDxELx®Cyclosporine Monoclonal Whole Blood Assay, P890025 4. Device Description The Emrit® 2000 Cyclosporine Specific Assay employs a homogeneous enzyme immunoassa…
Abbott Laboratories19891

Also cleared against P890025: 5 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has a recall.
  • 5 other devices also cite its predicate P890025.

How does its category compare?

All MKW devices

MKW Cyclosporine: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MKW

3in 2008

2008: 3
2007high 3 (2008) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MKW

177in 2008

2008: 177 days median
2007high 177 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · MKW

1in 2013

2010: 12011: 12013: 1
2007high 1 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MKW

8in 2025

2010: 22011: 1082012: 362013: 302014: 42015: 22016: 42018: 32019: 42020: 22021: 62022: 72023: 52024: 62025: 8
2007high 108 (2011) · low 0 (2007)2025

MAUDE reports naming product code MKW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
2008317700
20090—00
20100—12
20110—1108
20120—036
20130—130
20140—04
20150—02
20160—04
20170—00
20180—03
20190—04
20200—02
20210—06
20220—07
20230—05
20240—06
20250—08
20260—0—

What is it indicated for?

The Emit® 2000 Cyclosporine Specific Assay is for in vitro quantitative analysis of cyclosporine (CsA) in human whole blood as an aid in the management of cyclosporine therapy in kidney, heart and liver transplant patients.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K053061: Emit 2000 Cyclosporine Specific Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K053061

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026